XML 98 R80.htm IDEA: XBRL DOCUMENT v3.25.4
Condensed Financial Information (Parent Company Only) - Schedule of Condensed Balance Sheets Information (Details) - USD ($)
$ / shares in Units, $ in Thousands
Dec. 31, 2025
Dec. 31, 2024
Assets    
Total assets $ 1,065,786 $ 782,063
Liabilities and Stockholders' Equity    
Long-term debt, net of debt issuance costs 323,176 321,428
Total liabilities 886,509 681,108
Commitments and Contingencies (Note 14)
Stockholders' Equity:    
Preferred stock, $.001 par value; 100,000,000 shares authorized as of December 31, 2025 and 2024, respectively; no shares issued and outstanding as of December 31, 2025 and 2024 0 0
Common stock, $.001 par value; 1,000,000,000 shares authorized as of December 31, 2025 and December 31, 2024; 204,153,619 and 191,778,639 shares issued and outstanding as of December 31, 2025 and December 31, 2024, respectively 205 192
Additional paid-in-capital 1,188,089 1,107,952
Accumulated deficit (1,009,017) (1,008,293)
Total Alignment Healthcare, Inc. stockholders' equity 179,277 99,851
Total liabilities and stockholders' equity $ 1,065,786 $ 782,063
Preferred stock, par value (in dollars per share) $ 0.001 $ 0.001
Preferred stock, shares authorized (in shares) 100,000,000 100,000,000
Preferred stock, shares issued (in shares) 0 0
Preferred stock, shares outstanding (in shares) 0 0
Common stock, par value (in dollars per share) $ 0.001 $ 0.001
Common stock, shares authorized (in shares) 1,000,000,000 1,000,000,000
Common stock, shares issued (in shares) 204,153,619 191,778,639
Common stock, shares outstanding (in shares) 204,153,619 191,778,639
Parent Company    
Assets    
Investment in subsidiary $ 520,283 $ 425,033
Total assets 520,283 425,033
Liabilities and Stockholders' Equity    
Due to subsidiary 16,061 1,762
Accrued expenses 1,769 1,992
Long-term debt, net of debt issuance costs 323,176 321,428
Total liabilities 341,006 325,182
Commitments and Contingencies (Note 14)
Stockholders' Equity:    
Preferred stock, $.001 par value; 100,000,000 shares authorized as of December 31, 2025 and 2024, respectively; no shares issued and outstanding as of December 31, 2025 and 2024 0 0
Common stock, $.001 par value; 1,000,000,000 shares authorized as of December 31, 2025 and December 31, 2024; 204,153,619 and 191,778,639 shares issued and outstanding as of December 31, 2025 and December 31, 2024, respectively 205 192
Additional paid-in-capital 1,188,089 1,107,952
Accumulated deficit (1,009,017) (1,008,293)
Total Alignment Healthcare, Inc. stockholders' equity 179,277 99,851
Total liabilities and stockholders' equity $ 520,283 $ 425,033
Preferred stock, par value (in dollars per share) $ 0.001 $ 0.001
Preferred stock, shares authorized (in shares) 100,000,000 100,000,000
Preferred stock, shares issued (in shares) 0 0
Preferred stock, shares outstanding (in shares) 0 0
Common stock, par value (in dollars per share) $ 0.001 $ 0.001
Common stock, shares authorized (in shares) 1,000,000,000 1,000,000,000
Common stock, shares issued (in shares) 204,153,619 191,778,639
Common stock, shares outstanding (in shares) 204,153,619 191,778,639